BPS Pharmacotherapy Certification Examination Practice Test
The BPS Pharmacotherapy Certification Examination practice page focuses on medication selection, safe use, monitoring, and treatment adjustment across common clinical scenarios. Practice questions address applying pharmacology to patient-specific factors, recognizing adverse effects and interactions, and counseling patients about medication administration and risks.
Exam overview
About the BPS Pharmacotherapy Certification Examination Exam
Pharmacotherapy decisions require weighing indication, expected benefit, contraindications, organ function, concurrent medicines, and patient preferences. Relevant skills include identifying when a drug interaction may create a serious risk, interpreting symptoms or laboratory results that could signal toxicity, and selecting appropriate monitoring after treatment starts or changes. Questions also exercise practical decisions such as switching from intravenous to oral therapy when clinically appropriate, counseling on administration factors that affect absorption, and assessing response before modifying an established regimen. Clinical reasoning connects drug mechanism and adverse-effect profiles with the patient’s presentation—for example, recognizing when dopamine blockade may worsen Parkinsonian symptoms or when a medicine can affect potassium. These tasks reflect medication review, patient education, and follow-up planning used in pharmacotherapy practice.
Sample Practice Questions
Review a selection from this exam's published US Practice Tests practice bank.
A patient with hypothyroidism takes levothyroxine together with calcium carbonate at breakfast. Which counseling point may improve levothyroxine absorption?
Show answer
Correct answer: ACalcium can bind or otherwise reduce absorption of levothyroxine when taken together. Consistent administration on an empty stomach and separating interacting supplements by several hours can improve absorption and make thyroid test results more stable.
A hospitalized patient is transitioned from intravenous to oral medication for a condition with a well-absorbed oral formulation. Which general principle should guide the switch?
Show answer
Correct answer: AAn intravenous-to-oral switch can reduce line-related risks and resource use when the patient is clinically appropriate for oral treatment. Assess stability, gastrointestinal absorption, ability to take medication, infection or disease response, and drug-specific dose equivalence before making the change.
A patient with type 2 diabetes is starting empagliflozin. Which counseling point is most important regarding a rare but serious adverse effect?
Show answer
Correct answer: ASGLT2 inhibitors are associated with ketoacidosis that can occur with only modest glucose elevation. Symptoms such as nausea, abdominal pain, malaise, or rapid breathing warrant prompt evaluation, especially during acute illness, prolonged fasting, or surgery.
A patient taking an SSRI is prescribed a new medication for acute migraine. Which medication class raises a clinically important risk of serotonin toxicity and warrants review of the combination and patient-specific factors?
Show answer
Correct answer: ATriptans have serotonergic activity, and combining them with an SSRI may raise concern for serotonin toxicity. The absolute risk is generally considered low, but the prescriber should review the full medication regimen, counsel about concerning symptoms, and make an individualized risk-benefit decision.
A patient with heart failure is prescribed spironolactone. Which laboratory abnormality is especially important to monitor after initiation and dose changes?
Show answer
Correct answer: ASpironolactone can impair potassium excretion, so serum potassium and renal function should be monitored, particularly after initiation, dose changes, or changes in other medications that affect potassium balance.
A patient with Parkinson disease has been stable on carbidopa-levodopa but develops worsening motor symptoms after starting a dopamine-blocking antipsychotic. What is the most likely medication-related explanation?
Show answer
Correct answer: ADopamine receptor-blocking medications can worsen parkinsonian symptoms by reducing dopaminergic signaling. The medication regimen should be reviewed with the treating clinicians, considering the indication and alternatives with less potential to worsen motor symptoms.
A patient taking atorvastatin reports new, unexplained muscle pain and weakness. Which initial approach is most appropriate?
Show answer
Correct answer: ANew muscle symptoms warrant assessment, including timing, severity, interacting medicines, and other potential causes. Creatine kinase measurement and temporary interruption or modification of therapy may be appropriate depending on clinical findings; treatment decisions should be individualized.
How to use this practice test
Access is free. The practice bank contains 50 questions; a session presents up to 20 random questions and shows results afterward. Use the questions to check how you apply medication safety, monitoring, interaction assessment, and patient counseling in clinical situations, then revisit the decisions that were difficult.
Preparation tips
- For interaction questions, identify the mechanism and potential severity, then consider dose, duration, alternatives, and patient-specific risk factors.
- Connect each medication class to relevant monitoring: for example, consider potassium after starting or changing spironolactone and assess concerning muscle symptoms during statin therapy.
- Practice translating administration details into counseling, including spacing levothyroxine from calcium and following the prescribed role of an inhaler used for both maintenance and relief.
- When evaluating treatment response, distinguish inadequate duration or adherence from true lack of efficacy before recommending a change.
- For route changes, assess clinical stability, gastrointestinal absorption, formulation suitability, and whether the oral option can provide the intended therapy.